Author:
Jensen Juliana,Ma Li-Ping,Fu Michael L. X.,Svaninger David,Lundberg Per-Arne,Hammarsten Ola
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference30 articles.
1. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordonez-Llanos J, Santalo M, Pinto YM, Januzzi JL Jr (2007) Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167:400–407
2. Bionda C, Bergerot C, Ardail D, Rodriguez-Lafrasse C, Rousson R (2006) Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study. Ann Clin Lab Sci 36:299–306
3. Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50:2052–2058
4. Chenevier-Gobeaux C, Delerme S, Allo JC, Arthaud M, Claessens YE, Ekindjian OG, Riou B, Ray P (2008) B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients. Clin Biochem 41:1049–1054
5. Chua G, Kang-Hoe L (2004) Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 8:R248–R250